UPDATED May 03, 2024
Potentially undervalued companies with a strong past performance and robust balance sheet.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MSFT | US$406.66 | 0.08% | 30.9% | US$3.0t | US$476.88 | PE35.1x | E12.7% | 0.7% | Software | ||
GOOGL | US$167.24 | -2.7% | 58.4% | US$2.1t | US$190.91 | PE25.1x | E12.2% | 0.5% | Media | ||
META | US$451.96 | 2.0% | 94.2% | US$1.1t | US$518.35 | PE25.1x | E12.2% | 0.4% | Media | ||
2330 | NT$780.00 | -0.3% | 56.0% | NT$20.2t | NT$912.98 | PE23.6x | E16.1% | 1.8% | Semiconductors | ||
NOVO B | kr.850.60 | -4.1% | 55.5% | kr.3.8t | kr.908.80 | PE42.3x | E13.0% | 1.1% | Pharmaceuticals & Biotech | ||
CRM | US$273.66 | -0.2% | 38.5% | US$264.0b | US$337.07 | PE64.2x | E18.6% | 0.6% | Software | ||
ADBE | US$486.18 | 1.8% | 39.5% | US$213.5b | US$616.89 | PE45.4x | E17.1% | n/a | Software | ||
QCOM | US$179.64 | 8.4% | 65.1% | US$201.0b | US$185.20 | PE23.7x | E8.7% | 1.8% | Semiconductors | ||
NOVN | CHF87.97 | -1.7% | -5.6% | CHF179.5b | CHF98.16 | PE21.8x | E10.0% | 3.7% | Pharmaceuticals & Biotech | ||
PDD | US$140.18 | 8.4% | 122.3% | US$194.7b | US$181.10 | PE23.5x | E22.9% | n/a | Retail | ||
ROG | CHF217.30 | -1.7% | -23.4% | CHF175.2b | CHF279.39 | PE15.1x | E8.6% | 4.4% | Pharmaceuticals & Biotech | ||
AXP | US$230.77 | -2.1% | 51.2% | US$167.2b | US$227.57 | PE18.7x | E7.7% | 1.2% | Diversified Financials | ||
VRTX | US$401.08 | 0.9% | 15.2% | US$103.7b | US$460.23 | PE28.6x | E11.4% | n/a | Pharmaceuticals & Biotech | ||
SAF | €206.40 | -1.1% | 49.9% | €85.4b | €210.42 | PE24.8x | E7.1% | 1.1% | Capital Goods | ||
1299 | HK$61.35 | 13.6% | -24.8% | HK$686.9b | HK$94.33 | PE23.4x | E16.8% | 2.6% | Insurance | ||
CSL | AU$275.80 | 0.9% | -8.4% | AU$133.3b | AU$306.40 | PE35.5x | E14.7% | 1.3% | Pharmaceuticals & Biotech | ||
CRWD | US$310.21 | 2.0% | 153.3% | US$73.4b | US$390.51 | PE839.9x | E34.9% | n/a | Software | ||
SLB | US$47.66 | -3.1% | 4.2% | US$68.0b | US$66.67 | PE15.7x | E15.8% | 2.3% | Energy | ||
NTES | US$103.02 | 7.3% | 15.9% | US$63.8b | US$133.77 | PE16.3x | E7.9% | 2.5% | Media | ||
DSY | €36.92 | -2.3% | 1.1% | €48.6b | €44.04 | PE44.9x | E13.9% | 0.6% | Software | ||
2454 | NT$1,040.00 | 3.5% | 54.1% | NT$1.7t | NT$1,199.10 | PE21.5x | E13.3% | 5.8% | Semiconductors | ||
300760 | CN¥304.59 | 5.5% | -3.1% | CN¥368.4b | CN¥394.25 | PE30.3x | E15.1% | 1.9% | Healthcare | ||
SMCI | US$782.70 | -8.7% | 470.4% | US$44.6b | US$1,011.68 | PE43.7x | E37.6% | n/a | Tech | ||
BBRI | Rp4,750.00 | -1.7% | -9.1% | Rp717.8t | Rp6,258.00 | PB2.4x | E9.6% | 6.7% | Banks |